SCHEMBL7410862

SCHEMBL7410862

O=S(=O)(Cl)c1cc2c(cc1Cl)NC(CCl)NS2(=O)=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.63
▸ LMNA P02545 7/20 0.57
▸ ALDH1A1 P00352 4/20 0.57
▸ CYP2C9 P11712 3/20 0.57
▸ CYP1A2 P05177 2/20 0.57
▸ ADRA2B P18089 1/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ CYP3A4 P08684 4/20 0.54
▸ KDM4E B2RXH2 3/20 0.54
▸ HPGD P15428 1/20 0.54
▸ ATM Q13315 1/20 0.54
▸ CA2 P00918 3/20 0.51
▸ CA1 P00915 2/20 0.51
▸ HTT P42858 1/20 0.51
▸ CA12 O43570 1/20 0.51
▸ CA4 P22748 1/20 0.51
▸ CA6 P23280 1/20 0.51
▸ CA5A P35218 1/20 0.51
▸ CA7 P43166 1/20 0.51
▸ CA9 Q16790 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7350074 0.85 TDP1 (0.62) TDP1LMNAALDH1A1CYP2C9CYP1A2
SCHEMBL7405175 0.82 ALDH1A1 (0.65) TDP1LMNAALDH1A1CYP2C9CYP1A2
SCHEMBL13685945 0.78 TDP1 (0.79) TDP1LMNAALDH1A1CYP2C9CYP1A2
Ethiazide SCHEMBL30561875 0.77 TDP1 (1.00) TDP1LMNAALDH1A1CYP2C9CYP1A2
Ethiazide SCHEMBL122238 0.77 TDP1 (1.00) TDP1LMNAALDH1A1CYP2C9CYP1A2
SCHEMBL11038368 0.77 TDP1 (0.77) TDP1LMNAALDH1A1CYP2C9CYP1A2
SCHEMBL29925887 0.76 TDP1 (0.82) TDP1LMNAALDH1A1CYP2C9CYP1A2
Buthiazide SCHEMBL309110 0.75 TDP1 (0.76) TDP1LMNAALDH1A1CYP2C9CYP1A2
SCHEMBL7366786 0.75 TDP1 (0.72) TDP1LMNAALDH1A1CYP2C9CYP1A2
Buthiazide SCHEMBL29364486 0.75 TDP1 (0.76) TDP1LMNAALDH1A1CYP2C9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5015641-A Dipeptide for vision defects ANDREWS DAVID R (US) 1991-05-14 — — US disclosed
US-4885293-A CARBOXYALKYL DIPEPTIDES SCHERING CORPORATION (US) 1989-12-05 — — US disclosed
EP-0195817-B1 CARBOXYALKYLDIPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1989-10-18 — — EP disclosed
US-4826816-A Antihypertensive compounds SCHERING CORPORATION (US) 1989-05-02 — — US disclosed
US-4634698-A TOPICAL HYPOTENSIVES SCHERING CORPORATION (US) 1987-01-06 — — US disclosed
EP-0195817-A1 CARBOXYALKYLDIPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. SCHERING CORP (US) 1986-10-01 — — EP disclosed
WO-1986001803-A1 CARBOXYALKYLDIPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1986-03-27 — — WO disclosed
US-4556655-A TREATMENT OF CARDIOVASCULAR DISORDERS AND GLAUCOMA SCHERING CORPORATION (US) 1985-12-03 — — US disclosed
Send feedback